Mrv0541 05041404522D 18 19 0 0 1 0 999 V2000 1.3556 -0.1271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.3556 0.6979 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 2.0701 1.1104 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 2.0701 1.9354 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 1.3556 2.3479 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 0.6411 1.9354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1435 2.1904 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.6284 1.5229 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.1435 0.8555 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.6411 1.1104 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.6411 -0.5396 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.7845 0.6979 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.7845 2.3479 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.3556 3.1729 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.1681 0.5547 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 2.3522 0.3352 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 2.7845 1.5229 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 2.0701 2.7604 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 1 0 0 0 3 2 1 0 0 0 0 4 3 1 0 0 0 0 5 4 1 0 0 0 0 6 5 1 0 0 0 0 7 6 2 0 0 0 0 8 7 1 0 0 0 0 9 8 2 0 0 0 0 10 2 1 0 0 0 0 10 6 1 0 0 0 0 10 9 1 0 0 0 0 11 1 1 0 0 0 0 3 12 1 1 0 0 0 4 13 1 1 0 0 0 5 14 1 6 0 0 0 2 15 1 6 0 0 0 3 16 1 6 0 0 0 4 17 1 6 0 0 0 5 18 1 1 0 0 0 M END > DB02294 > drugbank > [H][C@]1(O)C2=NN=NN2[C@]([H])(CO)[C@]([H])(O)[C@]1([H])O > InChI=1S/C6H10N4O4/c11-1-2-3(12)4(13)5(14)6-7-8-9-10(2)6/h2-5,11-14H,1H2/t2-,3+,4+,5-/m1/s1 > UCJXQRFJERKPOZ-MGCNEYSASA-N > C6H10N4O4 > 202.168 > 202.070204828 > 7 > 24 > -1.0159832696038086e-05 > 17.415876616189298 > 1 > 4 > 0 > 0 > (5R,6S,7S,8S)-5-(hydroxymethyl)-5H,6H,7H,8H-[1,2,3,4]tetrazolo[1,5-a]pyridine-6,7,8-triol > -2.08 > -3.1920450916666665 > -0.63 > 0 > 0 > 2 > 0 > 13.275709611776739 > 12.024312060892035 > -1.9439076346013953 > 124.52000000000001 > 55.34129999999999 > 1 > 1 > 4.78e+01 g/l > biotin > 0 > DB02294 > EXPT01666 > experimental > (5R,6S,7S,8S)-5-hydroxymethyl-6,7,8-trihydroxy-tetrazolo[1,5-A]piperidine $$$$